While modern automated and point-of-care serological assays demonstrate high clinical accuracy on specific platforms, test performance varies widely by manufacturer, and limitations in specificity caution against routine general population screening.
Serological testing for HSV-2 demonstrates high accuracy on specific automated and point-of-care platforms, though performance varies by manufacturer and limitations caution against routine general population screening.